Purchase Order 75N95024P00495
Award Date
8/22/24
Potential Completion Date
8/21/25
Potential Value
$130K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Melior Discovery Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to QPS LLC, a minority-owned limited liability company, is for the provision of rodent pharmacokinetic (PK) testing services to support the National Institute of Neurological Disorders and Stroke's (NINDS) Helping to End Addiction Long-term (HEAL) initiative. The $98,000.00 firm-fixed-price purchase order contract has a period of performance through September 22, 2025. The contract was competitively awarded and does not have a set-aside designation. The services to...
This is a $7,323,160.93 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS). The contract is for continuous rodent and non-rodent pharmacokinetic assessments under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ contract. The prime contractor is SRI International, a large non-profit research and development institute that frequently partners...
This is a task order award under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract with the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,909,141.00 task order is for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" and has a completion date of May 19, 2022. The prime contractor is Sri International, a non-profit research institute that provides...
This is a $12,264.50 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Med Associates, Inc. The contract is for the delivery of custom rat behavior box parts to support an ongoing NIDA research project that started prior to January 20, 2025. This award was not set aside and is not associated with a larger contract vehicle. As a prime contractor, Med Associates has previously provided...
<p>This is a $531,600.00 Purchase Order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pearson Pharma Partners, a for-profit S Corporation. The contract is for a Subject Matter Expert Consultant to provide services related to Drug Metabolism Pharmacokinetics (DMPK) and has a period of performance through June 30, 2025. The contract was awarded on a labor hours pricing basis and does not have a set-aside designation.</p>
This federal contract award to SRI International, a non-profit research and development institute, is for $1,469,307.00 to conduct rodent and non-rodent pharmacokinetic studies. The contract is a delivery order issued under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master IDIQ contract with the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS)....
This is a federal contract award to Pharmaron, Inc., a global contract research organization (CRO) specializing in preclinical research services for the pharmaceutical and biotechnology industries, as well as government agencies. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), and is part of the NIH Bioanalysis Testing Services 2015-2020 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The...
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $113,400 contract is part of the NIH Bioanalysis Testing Services 2015-2020 IDIQ (Indefinite Delivery/Indefinite Quantity) vehicle. The work involves conducting pharmacokinetic assessments, toxicity studies, and ion channel testing services to support drug discovery and development efforts, including...
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Pharmaron, Inc. for $149,520.00. The award is under the NIH Bioanalysis Testing Services 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. Pharmaron, a minority-owned, for-profit contract research organization (CRO), will provide pharmacokinetics assessments, toxicity studies, and ion channel testing...
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational...